Altre lingue HeartBeam, Inc.

Azioni

BEAT

US42238H1086

Tempo reale stimato Cboe BZX Altri mercati azionari 21:00:39 27/06/2024			Variaz. 5gg	Var. 1 gen.
2,475 ^USD	-0,20%		+7,86%	+5,11%

20/05	HeartBeam, Inc. annuncia i dati di un nuovo studio che dimostra che HeartBeam AI combinato con la vettorcardiografia (VCG) supera i cardiologi esperti nel rilevare le aritmie	CI
09/05	Transcript : HeartBeam, Inc., Q1 2024 Earnings Call, May 09, 2024

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

HeartBeam's Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias	21/05
HeartBeam’s Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias	20/05
HeartBeam, Inc. Announces New Study Data Demonstrating That HeartBeam AI Combined with Vectorcardiography Outperforms Expert Cardiologists in Detecting Arrhythmias	20/05
HeartBeam AIMIGo Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program	14/05
HeartBeam AIMIGo™ Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards Program	13/05
HeartBeam Reports First Quarter 2024 Results	09/05
HeartBeam, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
HeartBeam to Host First Quarter 2023 Results Conference Call on Thursday May 9, 2024 at 4:30 p.m. Eastern Time	25/04
HeartBeam Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias	09/04
HeartBeam, Inc. Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias	09/04
HeartBeam : Fourth Quarter 2023 Earnings Conference Call Presentation	20/03
HeartBeam, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	20/03
HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results	20/03
First Patients Enrolled in Pivotal Study Evaluating HeartBeam's AIMIGo System for synthesizing a 12-Lead ECG	15/03
First Patients Enrolled in Pivotal Study Evaluating HeartBeam’s AIMIGo™ System for Synthesizing a 12-Lead ECG	14/03
HeartBeam, Inc. Announces First Patients Enrolled in Pivotal Study Evaluating HeartBeam's AIMIGo System for Synthesizing A 12-Lead ECG	14/03
HeartBeam Receives Two New US Patents for its Core Cardiac Monitoring Technology	07/03
HeartBeam, Inc. Receives Two New US Patents for Its Core Cardiac Monitoring Technology	07/03
HeartBeam to Host Fourth Quarter and Full Year 2023 Results Conference Call on Wednesday March 20, 2024 at 4:30 p.m. Eastern Time	05/03
HeartBeam, Inc. Announces Retirement of Richard Brounstein as Chief Financial Officer	05/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue HeartBeam, Inc.

Azioni

BEAT

US42238H1086

Altre lingue

Filtri